Samuel Kintz - Insider Trading & Ownership

Entity
Individual
Location
Enliven Therapeutics Inc, 6200 Lookout Road, Boulder, CO
Summary
The estimated net worth of Samuel Kintz is at least $30.1M dollars as of October 22, 2024. Samuel Kintz is the PRESIDENT AND CEO, Director of Enliven Therapeutics, Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $30.1M.
All Insider Reports
All Insider Reports

Ownership of Samuel Kintz

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ELVN Enliven Therapeutics, Inc. PRESIDENT AND CEO, Director $30.1M -$4.85M -13.9% Oct 18, 2024

Insider Transactions Reported by Samuel Kintz:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.